Some positive event must being around the corner. Otherwise, the director wouldn't freeze his own $77,167 (substantial money), if he hadn't had a confidence in the company’s future.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling